Arcadia Biosciences (RKDA) Competitors $4.44 -0.16 (-3.50%) As of 08/7/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RKDA vs. NCRA, PFAI, SEED, CEAD, EDBL, IVP, ORIS, SANW, SISI, and YTENShould you be buying Arcadia Biosciences stock or one of its competitors? The main competitors of Arcadia Biosciences include Nocera (NCRA), Pinnacle Food Group (PFAI), Origin Agritech (SEED), CEA Industries (CEAD), Edible Garden (EDBL), Inspire Veterinary Partners (IVP), Oriental Rise (ORIS), S&W Seed (SANW), Shineco (SISI), and Yield10 Bioscience (YTEN). These companies are all part of the "agriculture" industry. Arcadia Biosciences vs. Its Competitors Nocera Pinnacle Food Group Origin Agritech CEA Industries Edible Garden Inspire Veterinary Partners Oriental Rise S&W Seed Shineco Yield10 Bioscience Arcadia Biosciences (NASDAQ:RKDA) and Nocera (NASDAQ:NCRA) are both small-cap agriculture companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk and media sentiment. Do institutionals & insiders hold more shares of RKDA or NCRA? 17.7% of Arcadia Biosciences shares are held by institutional investors. Comparatively, 1.3% of Nocera shares are held by institutional investors. 1.8% of Arcadia Biosciences shares are held by company insiders. Comparatively, 5.3% of Nocera shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media refer more to RKDA or NCRA? In the previous week, Arcadia Biosciences' average media sentiment score of 0.00 equaled Nocera'saverage media sentiment score. Company Overall Sentiment Arcadia Biosciences Neutral Nocera Neutral Which has more volatility & risk, RKDA or NCRA? Arcadia Biosciences has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500. Comparatively, Nocera has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500. Do analysts recommend RKDA or NCRA? Arcadia Biosciences presently has a consensus target price of $6.00, suggesting a potential upside of 35.29%. Given Arcadia Biosciences' stronger consensus rating and higher possible upside, equities research analysts plainly believe Arcadia Biosciences is more favorable than Nocera.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arcadia Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Nocera 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is RKDA or NCRA more profitable? Nocera has a net margin of -12.70% compared to Arcadia Biosciences' net margin of -38.34%. Arcadia Biosciences' return on equity of -16.94% beat Nocera's return on equity.Company Net Margins Return on Equity Return on Assets Arcadia Biosciences-38.34% -16.94% -10.56% Nocera -12.70%-47.60%-35.67% Which has preferable earnings & valuation, RKDA or NCRA? Nocera has higher revenue and earnings than Arcadia Biosciences. Nocera is trading at a lower price-to-earnings ratio than Arcadia Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArcadia Biosciences$5.05M1.20-$7.04M-$4.28-1.04Nocera$16.65M1.41-$2.35M-$0.16-10.19 SummaryArcadia Biosciences and Nocera tied by winning 7 of the 14 factors compared between the two stocks. Get Arcadia Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RKDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RKDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RKDA vs. The Competition Export to ExcelMetricArcadia BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.29M$2.98B$5.48B$9.57BDividend YieldN/A2.46%3.99%4.17%P/E Ratio-1.0417.9729.8525.14Price / Sales1.20262.52422.3397.16Price / CashN/A41.8335.9458.58Price / Book0.977.238.125.59Net Income-$7.04M-$54.43M$3.26B$265.48M7 Day Performance5.72%0.22%0.68%1.22%1 Month Performance-6.63%5.59%2.46%0.39%1 Year Performance65.49%9.98%27.99%23.47% Arcadia Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RKDAArcadia Biosciences2.1045 of 5 stars$4.44-3.6%$6.00+35.3%+69.3%$6.29M$5.05M-1.0460Positive NewsUpcoming EarningsNCRANocera0.3281 of 5 stars$1.63+1.3%N/A+91.7%$23.11M$17.01M-10.1910Upcoming EarningsPFAIPinnacle Food GroupN/A$1.85-4.6%N/AN/A$22.70M$3.29M0.006Gap DownSEEDOrigin AgritechN/A$1.04-6.1%N/A-64.6%$7.94M$16.18M0.0060Positive NewsCEADCEA IndustriesN/A$8.88+3.8%N/A+164.1%$7.12M$3.28M-2.0430Upcoming EarningsGap UpEDBLEdible Garden0.6213 of 5 stars$2.46-5.7%N/A-91.9%$4.32M$13.86M-0.0450News CoveragePositive NewsUpcoming EarningsIVPInspire Veterinary Partners0.6989 of 5 stars$0.76-1.8%N/A-99.5%$3.98M$16.59M-0.03156News CoverageUpcoming EarningsGap DownORISOriental RiseN/A$0.16-8.5%N/AN/A$3.85M$15.01M0.00N/AGap DownSANWS&W Seed3.3535 of 5 stars$1.68-5.1%$25.00+1,388.1%-94.7%$3.80M$60.44M-0.12180Positive NewsGap UpSISIShineco0.4802 of 5 stars$0.15-13.2%N/A-98.3%$3.67M$9.80M0.0070News CoverageStock SplitGap DownHigh Trading VolumeYTENYield10 BioscienceN/AN/AN/AN/A$257K$60K0.0030Upcoming Earnings Related Companies and Tools Related Companies NCRA Competitors PFAI Competitors SEED Competitors CEAD Competitors EDBL Competitors IVP Competitors ORIS Competitors SANW Competitors SISI Competitors YTEN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RKDA) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcadia Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcadia Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
